The toxicology of orally administered Δ9-tetrahydrocannabinol in sheep
Abstract Introduction: As part of a larger study to assess the potential value of industrial hemp biomass (the low Δ9-tetrahydrocannabinol…
Leon N. Warne
Cannabidiol Enhances the Therapeutic Efficacy of Olsalazine and Cyclosporine in a Murine Model of Colitis
Abstract Current therapies for inflammatory bowel disease (IBD), such as olsalazine and cyclosporine, often exhibit limited long-term efficacy and are…
Improvements in health-related quality of life are maintained long-term in patients prescribed medicinal cannabis in Australia: The QUEST Initiative 12-month follow-up observational study
Abstract Aims: Since 2016, more than one million new patients with chronic health conditions have been prescribed medicinal cannabis in…
Targeting the Endocannabinoidome: A Novel Approach to Managing Extraintestinal Complications in Inflammatory Bowel Disease
Abstract Background: Inflammatory bowel disease (IBD) is a chronic inflammatory disorder marked by persistent gastrointestinal inflammation and a spectrum of…
The Pharmacokinetics of Δ9-Tetrahydrocannabinol in Sheep
Abstract Industrial hemp biomass, the low Δ9-tetrahydrocannabinol variety of Cannabis sativa, has been identified as a potential feed for ruminants.…
Pharmacohistory of Cannabis Use—A New Possibility in Future Drug Development for Gastrointestinal Diseases
Abstract Humans have employed cannabis for multiple uses including medicine, recreation, food, and fibre. The various components such as roots,…
Health-related quality of life in patients accessing medicinal cannabis in Australia: The QUEST initiative results of a 3-month follow-up observational study
Abstract Aims: Patients with chronic health conditions not responding to conventional treatment can access medicinal cannabis (MC) prescriptions from clinicians…